CASI Pharmaceuticals, Inc. (CASI) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CASI Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.11x | -3.55x | -0.60x | -2.97x | -6.75x | -6.54x |
| P/B Ratio | 23.45x | 3.96x | 0.55x | 1.29x | 4.00x | 4.06x |
| P/S Ratio | 1.52x | 2.82x | 0.57x | 3.61x | 21.52x | 71.77x |
| Profitability | ||||||
| Gross Margin | 39.1% | 59.2% | 63.3% | 58.4% | 37.2% | 4.7% |
| Operating Margin | -138.8% | -74.0% | -61.5% | -137.6% | -348.6% | -968.1% |
| Net Margin | -137.6% | -79.5% | -95.1% | -121.5% | -318.9% | -1098.1% |
| EBITDA Margin | -122.2% | -63.6% | -55.8% | -110.7% | -207.1% | -906.1% |
| Liquidity | ||||||
| Current Ratio | 1.09x | 3.55x | 4.32x | 4.70x | 9.28x | 7.74x |
| Quick Ratio | 0.94x | 2.60x | 3.96x | 4.56x | 9.11x | 7.17x |
| Leverage | ||||||
| Debt/Equity | 11.96x | 0.88x | 0.03x | 0.05x | 0.04x | 0.03x |
YoY = year-over-year change. Source: FMP..